Skip to content

Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial

Effects of Antimicrobial Peptides Application after Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis: A Randomized Clinical and Microbiological Trial - AMPs

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047711
Enrollment
51
Registered
2022-06-01
Start date
2018-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In this randomized clinical trial, we aimed to evaluate the effects of AMPs as an addition to SRP on clinical parameters and microbiological biofilms in patients with Stage III and Grade B periodontitis.

Interventions

SRP with AMPs group (AMP group)/SRP group SRP with AMPs group (AMP group)/SRP with minocycline hydrochloride group (Perio group)

Sponsors

Department of Periodontics,Beijing Stomatological Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria were: (1) at least 20 years old, (2) previously untreated Stage III and Grade B periodontitis by clinically and radiologically17, (3) a minimum of 20 natural teeth in the mouth, and more than 4 molars.

Exclusion criteria

Exclusion criteria: The exclusion criteria were: (1) acute oral lesions or necrotizing ulcerative periodontitis, (2) having received antibiotics within 6 months or the need for antibiotic coverage during experiment, (3) being allergic to minocycline, (4) no orthodontic treatment, (5) a history of systemic diseases, (6) pregnancy, (7) smoker

Design outcomes

Primary

MeasureTime frame
probing depth,clinical attachment level,Bleeding index, and Microbiological results

Countries

Asia(except Japan)

Contacts

Public ContactNannan Han

Beijing Stomatological Hospital, Capital Medical University CCMU

morose2012@sina.cn86-10-57099450

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026